Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate-day vs Daily Oral Iron Therapy in Children With Iron Deficiency Anaemia
NCT07391371Phase 4Not yet recruiting
- Sponsor
- University of Medicine, Mandalay
- Start
- Feb 2026
- Primary completion
- Oct 2026
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of iron polymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by University of Medicine, Mandalay. Primary endpoint: Efficacy of alternate-day versus daily oral iron therapy at 1 year. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
iron polymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07391371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391371.